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Objective: In vitro expansion is an important step to acquire sufﬁcient cells in human tissue engineering
technologies. The high number of chondrocytes needed for human articular cartilage implants requires
in vitro expansion of the primary cells, bearing a theoretical risk of in vitro induced changes in the
genomes. To gain more insights into this situation, model cultures were prepared and analyzed.
Design: 25 chondrocyte cell DNA samples from nine donors were analyzed by array comparative genomic
hybridization (aCGH) on whole genome level and 28 chondrocyte cell samples from 16 individuals were
analyzed by ﬂuorescence in situ hybridization (FISH) on single cell level. The expanded cells were further
characterized upon the chondrocytic mRNA phenotype by reverse-transciptase polymerase chain reac-
tion (RT-PCR).
Results: The molecular karyotyping results revealed autosomal stability, but all male samples analyzed by
aCGH displayed a variable loss of the Y-chromosome. These datawere conﬁrmed by FISH-experiments and
suggest an age dependant effect toward the loss of the Y-chromosome in cultured chondrocytes. RT-PCR
data for the mRNAs from collagen types I, II, and aggrecan and the pro-inﬂammatory cytokine inter-
leukin-1ß (IL-1ß) did not reveal any correlation of transcriptional activity in cultures with Y-chromosome
losses, nor were there statistically signiﬁcant differences between cells from female and male donors.
Conclusions: While cells of male origin may suffer from an age-related loss of the Y-chromosome, there was
no indication of a functional impairment. The data suggest some caution toward applying proliferative steps
when considering chondrocytes from elderly male patients for tissue engineering approaches.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular chondrocyte implantation (ACI) is a procedure of
regenerative medicine to repair small to medium sized cartilage
defects to prevent future progression into osteoarthritis (OA), thus
eliminating or delaying the necessity for early total knee endo-
prosthesis (TEP)1. One main goal of future development is to extend
this biological treatment from a conﬁned number of patients to the






s Research Society International. Pstages of OA. In current ACI procedures, the cells are harvested from
a patient, then cultivated (multiplied) in special GMP facilities
(Good Manufacturing Practice, a regulatory term to describe
speciﬁc quality and production control) and subsequently trans-
planted into the affected organ for tissue replacement or repair.
Obviously, such procedures depend largely on the proliferative
potential of the harvested cells. Since OA is prominently a disease of
the elderly, there might be a theoretical risk of age-dependent or
disease-dependent alterations in the chromosomal status of such
cells before and after in vitro cultivation, and a risk for the conse-
quences of such potential alterations on the cellular metabolism
and the cells’ ability to repair the tissue defect. The occurrence of
chromosomal abnormalities in serially passaged cell cultures is
common knowledge. Less is known about the theoretical risk
toward deviations from the normal diploid state of cells during
their growth in vitro in non-passaged primary cultures, making it
difﬁcult to assess the risk factor for patients undergoing a regen-
erative procedure like ACI. Only two ﬂow cytometry studies wereublished by Elsevier Ltd. All rights reserved.
Table II
FISH patients all male
Donors Age Ethnicity Tissue quality Primary cells Cell culture days
P002 77 Caucasian OA cartilage  14 FGF
H1282 75 Hispanic Healthy cartilage þ 14
P2710 36 Caucasian OA cartilage þ No sample
H1285 72 Caucasian Healthy cartilage þ 17
H1286 74 Caucasian Healthy cartilage þ 18
H1288 66 Hispanic Healthy cartilage þ No sample
4130093 30 Caucasian Healthy cartilage þ 11
H1300 72 Caucasian Healthy cartilage þ 15
H1301 52 Caucasian Healthy cartilage þ 15
H1302 64 Caucasian Healthy cartilage þ 15
H1305 47 Caucasian Healthy cartilage þ 14
H1306 74 Caucasian Healthy cartilage þ No sample
H1309 70 Caucasian Healthy cartilage þ No sample
H1315 69 Caucasian Healthy cartilage þ 19
H1325 70 Caucasian Healthy cartilage þ 19
H1328 20 Hispanic Healthy cartilage þ 19
M. Stumm et al. / Osteoarthritis and Cartilage 20 (2012) 1039e10451040performed showing no such changes in tissue engineered human
articular cartilage2,3.
In our studywe investigated the genomic stability of chondrocytes
during the expansion phase of cell culture by molecular karyotyping
using BAC (bacterial artiﬁcial chromosome) array-based comparative
genomic hybridization (aCGH) onwhole genome level. Furthermore,
aCGH results were validated by ﬂuorescence in situ hybridization
(FISH) on single cell level. In order to simulate additional proliferative
stress,we incubated cultures in thepresenceof FGF-2 as an additional
stimulus. The chromosomal data were then compared to real-time
reverse-transciptase polymerase chain reaction (RT-PCR) data from
a set of select genes resp. their mRNAs. The obtained data do not
indicate particular genetic risks associated with ACI.
Material and methods
Tissue
There were two sources of human chondrocytes: articular
cartilage tissue from patients with total knee replacement surgery
(“OA” cartilage, with patient consent and approval from local ethics
committee, University of Tübingen, Germany) and healthy cartilage
from human organ donors (Articular Engineering, Skokie, Illinois,
USA) (see Tables I and II).
Cell culture
Normal-looking cartilage from TEP patients and cartilage tissue
plugs harvested from organ donors (Fig. 1) was subjected to
a collagenase-protease digestion procedure as described4. The
freshly isolated cells (day 4, D4) were in part directly analyzed for
chromosomal abnormalities (aCGH and/or FISH), in part expanded
in primary culture in vitro. The primary culture was performed by
seeding cells at low density (approx. 1500e2500 cells/cm2) into
culture ﬂasks and allowing them to undergo 6e7 cell divisions
prior to harvest. The cells were cultured in DMEM/F12 medium
supplemented with 10% homologous human serum, in the absence
of antibiotics. In cultures from nine individuals, a parallel cultiva-
tion was made and the medium was additionally supplemented
with 10 ng FGF-2 (Miltenyi Biotech, Bergisch-Gladbach, Germany)
per ml medium to add a proliferative stimulus to the baseline
condition. After indicated days (e.g., “D0, D4, D14, D19, D19þ FGF,
etc”) in culture, the cell were harvested by trypsination and also
submitted to aCGH and/or FISH as described below. One reference
culture each was harvested and used for gene expression analysis.
In some cases, cells were seeded into a collagen sponge scaffold
prior harvest (Table III).
DNA isolation
High-molecular-weight genomic DNAs from cell culture speci-
mens were extracted according the manufacturer’s instructionsTable I
aCGH patients
Donors Age Ethnicity Sex Origin
P001 74 Caucasian Female OA cartilage
P002 77 Caucasian Male OA cartilage
P003 55 Caucasian Female OA cartilage
P004 69 Caucasian Female OA cartilage
P041 73 Caucasian Female OA cartilage
P042 54 Caucasian Female OA cartilage
P057 77 Caucasian Male OA cartilage
P063 82 Caucasian Male OA cartilage
H1250 67 Caucasian Male Healthy cartilageusing the Qiagen Blood & Cell Culture Kit (Qiagen, Germany). Only
DNA with good QC-measures was used in the aCGH-experiments.
aCGH
25 chondrocyte cell/DNA samples from nine donors were
analyzed by aCGH on whole genome level. The Constitutional Chip
4.0 Kit from Perkin Elmer was used for aCGH-experiments. That
array provides an average backbone resolution less than 1 MB and
an enhanced resolution in regions that are known for higher
chromosomal instability (microdeletion and microduplication
regions) as well as in centromeric and subtelomeric regions.
Labeling, hybridization and washing were performed following the
supplier’s protocols. In brief, donor matched DNA from early cell
culture (D4) was hybridized against DNA from late cell culture cells
(D19 FGF). This strategy prevents cell culture independent copy
number changes (CNCs) from control DNA. Sex-matched commer-
cial DNA samples [Promega] were only used as reference DNA, if no
internal cell culture control DNA was available. Micro-arrays were
scanned with the Innoscan700 scanner (Innopsys). Scanned images
were extracted and analyzed, using the software oneClickCGH 4.3.3
(Perkin Elmer). The coordinates are based on NCBI 36 Genome
Build (HG18, March 2006).Fig. 1. Femoral head of a healthy human organ donor knee (H1306). The holes are the
harvest sites for the articular cartilage used here. Note that the slightly damaged area
to the right was not used.
Table III
Results from aCGH
Patients aCGH compared sets Chromosomal changes Interpretation
P001 D4/D18 No changes Euploid
D18/D18þ FGF No changes Euploid
P002 D4/D19 Loss Y-chromosome mosaicism in D19 Mosaic 46,XY/45,X,Y in D19
D19/D19þ FGF No changes Mosaic 46,XY/45,X,-Y similar in both cultures
D19þ FGF/D4 Gain Y-chromosome mosaicism in control (reverse aCGH) Mosaic 46,XY/45,X,Y in D19þ FGF
P003 D4/D19 No changes Euploid
D19/D19þ FGF No changes Euploid
D4/scaffoldþ FGF No changes Euploid
Scaffold/D19þ FGF No changes Euploid
P004 D4/D19 No changes Euploid
D19/scaffoldþ FGF No changes Euploid
P041 Control/D19 No changes Euploid
Control/D19þ FGF No changes Euploid
D19/D19þ FGF No changes Euploid
P042 Control/D19 No changes Euploid
Control/D19þ FGF No changes Euploid
D19/D19þ FGF No changes Euploid
P057 D4/D19 Loss Y-chromosome; mosaicism in D19 Mosaic 46,XY/45,X,Y in D19
D19/D19þ FGF Loss Y-chromosome; mosaicism in D19þ FGF Mosaic 46,XY/45,X,Y more signiﬁcant in D19þ FGF
Control/D4 No changes Euploid
P063 D4/D19 Loss Y-chromosome in D19 45,X,Y in D19
D19/D19þ FGF Loss Y-chromosome in D19þ FGF 45,X,Y more signiﬁcant in D19þ FGF
Control/D4 No changes Euploid
H1250 Control/D19 Loss Y-chromosome in D19 45,X,Y
Control/D19þ FGF Loss Y-chromosome in D19þ FGF 45,X,Y
D19/D19þ FGF No changes Mosaic 46,XY/45,X,Y similar in both cultures
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Twenty-six chondrocyte cell samples from 15 donors were
analyzed by interphase-FISH on single cell level. Commercial FISH
probes CEP X,Y,18 from the prenatal AneuVysion Kit (Abbott) or XA
X,Y,18 from the prenatal AneuScore Kit (Metasystems) were used
for FISH-experiments. The experimental procedures are standard-
ized in our laboratory and already published5. For analysis, the
signals for chromosome X and chromosomes 18 were used as
internal controls. Only cells with normal signal constellations for
these chromosomes (one green X-signal and two aqua 18-signals)
were used for Y-chromosome analysis. The strategy reduces
misinterpretations due to technical artefacts.
Gene expression analysis
Harvested cells were immediately dissolved in RNA extraction
buffer (RLT buffer) and RNA was prepared with RNeasy Mini Kit
(Qiagen, Germany) and DNA eliminated by RNase-Free DNase Set
(Qiagen, Germany) according to the manufacturer’s instructions.
Total RNA content and purity were estimated by photometry (260/
280 nm ratio). One microgram RNA was reversely transcribed into
cDNA by using the Advantage RT-for-PCR kit (Takara Bio Europe)
and according to the manufacturer’s protocols. Real-time RT-PCR
was performed on a Lightcycler 480 (Roche, Mannheim, Germany)
using validated Lightcycler-speciﬁc ampliﬁcation kits (Search-LC,
Heidelberg, Germany) for collagen types I and II (COL1, COL2),
aggrecan (ACAN), interleukin-1ß (IL-1ß), and glyceroaldehyde
phosphate dehydrogenase (GAPDH). The data for collagens, ACAN
and IL-1ß were normalized to GAPDH and are presented as nega-
tive delta cycle threshold numbers (“dCt”), with the thresholds
being deﬁned by the automated evaluation program of Lightcycler
480. PCR performance was additionally monitored by the ampliﬁ-
cation of gene standards provided in the Search-LC kits.Statistics and graphs
To evaluate the data sets, the program SigmaPlot v. 12 has been
employed both for graphical presentation and statistical analysis.




aCGH analyses were performed with 25 different DNA samples
of chondrocyte cells from ﬁve female and four male donors with an
age between 54 and 82 years. For the female donors the age ranged
from 54 to 74 years. For the male donors the age ranged from 67 to
82 years (see Table I). An aCGH strategy was employed hybridizing
donor matched DNA from early cell culture cells (D4) against DNA
from late cell culture cells with and without FGF-2(D19 FGF) (see
Table III). This strategy does not produce CNCs as side effects from
control DNA. In contrast, it detects only cell culture dependant de
novo aberrations. Sex-matched commercial DNA samples were only
used for reference if not sufﬁcient internal control DNA was avail-
able, or to test if aberrations were already present in the early cell
culture (D4).
Within the brackets of the technical limitations of aCGH,
molecular karyotyping detected no autosomal imbalances in the
donor chondrocytes. Balanced structural chromosome aberrations
as well as low level mosaics are not detectable by aCGH, but the
diagnostic resolution <1 Mbp is much higher compared to
conventional karyotyping (5e10 Mbp). Neither cell expansion by
long term culture nor the use of growth factors induced a gain or
loss of DNA in the autosomal DNA (see Table III: all patients).
Additionally, no sex chromosome anomalies were detected in the














in % after expansion
Difference expansion initial
H1282 75 þ 400 29.75 14 400 43.25 13.5
P2710 36 þ 400 38.25 No data
H1285 72 þ 400 39.5 17 400 30.25 9.25
H1286 74 þ 400 19.5 18 400 30.5 11
H1288 66 þ 400 3.5 No data
4130093 30 þ 400 2.25 11 400 2.5 0.25
H1300 72 þ 400 1.25 15 430 29.77 28.52
H1301 52 þ 400 1.75 15 430 10.47 8.72
H1302 64 þ 400 0.5 15 400 27.25 26.75
H1305 47 þ 410 0 14 400 1.75 1.75
H1306 74 þ 400 2.5 No data
H1309 70 þ 400 9.5 No data
H1315 69 þ 400 3.75 19 400 28 24.25
H1325 70 þ 800 2.25 19 400 7.25 5.0
H1328 20 þ 400 0 19 400 0.5 0.5
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sequences to various degrees. The aCGH proﬁles of P002 and P057
showed an incomplete loss of Y-chromosomal sequences, indi-
cating a mosaic constellation in the analyzed cells (see Table III).
The aCGH proﬁles of P063 and H1250 showed a more pronounced
loss of Y-chromosome sequences, indicating a nearly complete loss
of the Y-chromosome (see Table III). In two patients (P057 and
P063) the Y-chromosome loss was more signiﬁcant in the cultures
with FGF-2, whereas in the other two patients the Y-chromosome
loss was similar, in the culture with and without FGF-2. Therefore,
FGF-2 seems not to have a signiﬁcant effect on the loss of the
Y-chromosome during cell culture.
A ﬁrst preliminary FISH experiment on T14 and T14þ FGF-2 cells
(day 14 of cell culture) from P002 conﬁrmed the loss of the
Y-chromosome in up to 45% and 90% of analyzed interphase cells in
day 14 cell culture cells (see Table IV). Because of the limited quality
of the frozen cell samples only 20 cells were analyzed per sample.
In summary, aCGH detected a loss of the Y-chromosome in all
expanded male samples (see Table III: P002, P057, P063 andFig. 2. Correlation analysis between the age of the cartilage donor and the frequency of
the Y-chromosome loss found immediately after releasing the cells from the tissue
(dots, continuous regression line) and after primary expansion culture (crosses, dashed
regression line). Regression coefﬁcient of linear regressions¼ r2. The correlation
coefﬁcient (“corr coeff”) was calculated via the Pearson Product Moment (including its
statistical signiﬁcance P).H1250). By aCGH, the loss was not detectable in the starting
cultures (see Table III: P057 and P063). However, the high degree of
Y-chromosome loss in the expanded cultures suggests that the loss
was already initially present. Therefore, FISH-analyses were per-
formed on further donor cells to test this hypothesis on single cell
level.
Fluorescent in situ hybridization (FISH) analysis
Single cell analysis by FISH detected a Y-chromosome loss
already present in the freshly isolated cells (Fig. 2). FISH conﬁrmed
an increased Y-loss during cell culture. The increase of the
Y-chromosome loss in the FISH-experiments demonstrated an
approximately age dependant effect, however, without becoming
statistically signiﬁcant (Tables IV and V, Fig. 2). In contrast, to
a signiﬁcant extent, the Y-chromosome losses that occurred during
cultivation were age-dependent, caused by marked increases of
losses in the cultures from the donors with advanced age (Fig. 2). In
one case (H1285), there was a slight change toward more normal
nuclei after in vitro cultivation (Table IV).
Gene expression data
Known key genes for chondrocyte functions are located on
autosomes rather than sex chromosomes. Nonetheless, potent
regulatory elements like SOX-9 are related to or deduced from sex
genes and, hypothetically, may be inﬂuenced by the loss of
a complete chromosome. Therefore the expression of the extra-
cellular matrix coding mRNA for COL1 alpha 2 chain, for COL2 alpha
1 chain, and for the ACAN core protein were studied. In addition,
IL-1ßmRNAwas analyzed since chondrocytes tend to activate IL-1ß
under stress. As detailed in Fig. 3(A, B), and in Table V, there was no
detectable change in gene expression, neither in the comparison
between male and female, nor within the group of cell cultures
from male donors with various degrees of Y-chromosome
deletions.Table V
Statistical data to Fig. 2: correlation analysis (n¼ 12)







Fig. 3. A: comparison of gene expression levels in total 28 males and females. Gene
expression levels are presented as dCt, calculated from the ampliﬁcation data for the
reference gene GAPDH and the corresponding gene, as indicated on the x-axis. The
letter “f” next to the name of the gene indicates data for females, “m” the corre-
sponding data for males. The box plot depicts 25/75 percentiles as boxes, plus median
(horizontal line in box), plus 10/90 percentiles (capped lines), plus 95% conﬁdence
intervals (black dots). Signiﬁcance was calculated by Student’s t test on female vs male
groups for each mRNA. Expression values are given as relative data (dCt) from the cycle
thresholds (Ct), with GAPDH as reference gene. B: correlation analysis of the data from
(A), presented from the individual analyses, to the percentual loss of the Y-chromo-
some in each cell culture. Data derived from 12 donors. None of the obtained hori-
zontal regression curves indicates signiﬁcant correlations (COL1, coeff¼ 0.0986
P¼ 0.761; COL2, coeff¼ 0.277 P¼ 0.384; ACAN, coeff¼ 0.049 P¼ 0.880; IL-1ß, coef-
f¼0.327 P¼ 0.300). C: effect of FGF-2 supplementation on gene expression (relative
to GAPDH). Data derived from nine donors. None of the genes displayed a signiﬁcant
(P< 0.05, ManneWhitney rank sum test) alteration by the addition of 10 ng FGF-2/ml
culture medium. The boxes indicate the 25/75 percentiles, the dots 95% conﬁdence
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The addition of FGF-2 was made to exert a mild but distinct
proliferative stimulus to the basic conditions with the serum
supplement alone. FGF-2 led to a small but statistically signiﬁcant
increase in themitotic activity, reducingmitotic doubling time from
approximately 3.7 days to 3.0 days or an increase in total cumula-
tive population doublings from 5.871.2 to 6.951.3 (mean, SD,
P¼ 0.005) within 19 days in vitro. In contrast to the effect on
mitosis, therewas no signiﬁcant change in any of the analyzed gene
expressions, irrespectively of sex or Y-chromosome status
[Fig. 3(C)]. There was also no correlation of FGF-2 treatment as such
to the extent of Y-chromosome losses (data not shown).
Discussion
Autosomal stability
The molecular karyotyping by aCGH detected no autosomal
anomalies in the cultivated chondrocytes, neither before nor after
cell expansion, and either with or without the substitution of FGF.
Only a limited number of conventional cytogenetic reports are
available from chondrocytes. Post-mortem gained chondrocytes
from a young patient withMajewski syndrome do not show speciﬁc
chromosome anomalies6. Furthermore, fetal chondrocytes from
missed abortions, IUFT and stillbirth do not show speciﬁc chro-
mosome anomalies7.
In contrast, from another study, eight post-mortem specimens
from old donors analyzed by GTG-banding showed high frequency
of aneuploidies8. Predominantly loss of one gonosome and gains of
chromosomes 5, 7, 8 and gonosomes were detected. Interestingly,
all these aberrations were already present in the ﬁrst passage
directly after the establishment of the cell culture, suggesting their
presence in the original cartilage tissue. In the same study, ﬁve
samples from younger patients with cartilage damage showed
mostly normal karyotypes with negligible single non-clonal events
of numerical and structural aberrations8. These results are in
concordance with past studies showing for a limited number of
donors, that chondrocytes subjected to knee surgery showed
a normal karyotype9 and that even extensive expansion of the
chondrocytes had no effect on chromosome number or structure10.
Additionally, two ﬂow cytometric studies have not shown changes
of DNA content in tissue engineered human articular cartilage2,3.
Autosomal genetic abnormalities have been found in cartilagi-
nous tumors. A conventional cytogenetic analysis of 21 benign
chondromatous tumors showed that the most common affected
genomic regions were all autosomal. Abnormalities of chromo-
somes 5, 6, 7 and 12, and additionally of chromosomal regions
6q13, 12q13 and 17p13 are shared by both malignant and benign
cartilaginous tumors11. SKY- and FISH-analyses on 10 chon-
drosarcoma samples showed different translocations and trisomies
of chromosomes 1q, 7, 8, 12 and 1912. BAC-/PAC-aCGH analyses on
15 frozen chondrosarcoma samples and FISH with a MYC-probe on
116 samples showed polysomy 8 and MYC ampliﬁcation as
common aberration13. Oligo-aCGH analyses on 23 frozen samples
showed deletions in chromosomes 5q, 6q and 9p14.
Nevertheless, none of these tumor speciﬁc cytogenetic aberra-
tions were detected in our analyzed chondrocyte samples.
All these results suggest that cell culture and tissue engineering
techniques do not inﬂuence the autosomal integrity and genomic
stability of normal human chondrocytes.intervals, the horizontal lines within the boxes the medians, and the capped lines
10/90 percentiles.
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In contrast to the ﬁndings for autosomes and X-chromosomes,
aCGH detected a loss of the Y-chromosome in all male samples.
Single cell analysis by FISH conﬁrmed hypoploidy of the
Y-chromosome immediately after extracting the cells from the
tissue. FISH and aCGH detected also an increased Y-chromosome loss
during cell culture. The increase in Y-negative FISH samples suggests
an age dependant de-stabilizing effect.
A similar effect was detected by Trimborn et al.8. In eight post-
mortem specimens from old donors (mean age 58.1 years) a high
frequency of Y-chromosome loss was detected by conventional
cytogenetic analyses. In contrast, ﬁve younger patients (mean age
24 years) did not show this effect.
The loss of Y-chromosomes has also been described in patients
with hematological malignancies representing a disease associated
chromosome marker15. However, several other studies have shown
that a Y-chromosome loss is a relatively common event in bone
marrow and peripheral blood cells of elderly males16,17. Sponta-
neous loss of the Y-chromosome was also described in mesen-
chymal stem cells18. All in all, the loss of the Y-chromosome should
be considered as part of the normal aging process. It is important to
remember that cartilage is a postmitotic tissue19. Cell divisions take
only place during fetal development and potential early childhood.
Thereafter, no cell renewal cycles are reported to have been
observed. Therefore, any loss of Y-chromosomes must have
occurred during early lifetime. Nevertheless, a cumulative effect of
the cell culture condition for the loss of the Y-chromosome cannot
be excluded at the moment.
Aneuploidic mosaics in vivo are not uncommon, in particular
during embryogenesis20. Out of 25 pre-implantation embryos only
two contained normal chromosomal sets, and modiﬁcations in Y-
chromosome content rather typical. Ferrier und Kelly21 report on
a newborn child with Y-chromosome-free cells in various organs
(skin 20%, leukocytes 8%, and gonads 14%). In osteoarthritic tissue,
by FISH analysis, Castellanos et al.22 found Y-chromosome deple-
tions in all male patients and in healthy controls in three out of ﬁve.
Ultimatively, all Turner syndrome patients (X0) are proof for
a metabolic independence of cartilage formation and maintenance
since there is no literature on joint cartilage anomalies in X0
phenotypes. The presence or absence of the Y-chromosome did not
affect the transcriptional capacity of the chondrocytes with regard
to the tested mRNAs. Neither did the comparison female vs male
reveal any metabolically signiﬁcant differences, nor did the partial
loss of the Y-chromosome induce any changes, nor did the
administration of FGF-2 lead to measurable changes in any of those
groups. These ﬁndings ﬁt to the above cited ﬁndings toward skel-
etal normality despite variations in cellular Y-chromosome content.
Conclusions
The presented data sets extend our knowledge on in vitro events
concerning autosomal and sex chromosomal patterns. The study is
limited by the fact that only primary cultures were explored and that
no data on translational and/or posttranslational metabolic effects
were investigated. However, from the data it can be concluded that
Y-chromosomal losses are quite normal in chondrocyte tissue
cultures. To-date, several 10,000, probably hundred thousand young
and medium aged patients have received ACI based on similar cells
expansion protocols as presented here, without any critical incidents
having been reported, such as tumor development, among them
a proportional number of male patients. When taken together, the
data presented here and the clinical experiencewith ACI suggest that
a loss of Y-chromosome poses no risk toward failure of cartilage
tissue engineered products. However, more investigations areneeded to evaluate the risk for elderly and osteoarthritic patients
prior to an extension of ACI into such patient groups.Contributions
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